Stimulant medications for attention-deficit/hyperactivity disorder cause sleep problems among the children who take them, a study from the University of Nebraska-Lincoln (UNL) concludes.
Inspire Medical Systems Inc this month announced the results of a landmark long-term clinical study for its Inspire Upper Airway Stimulation (UAS) System, the first FDA-approved implantable neurostimulation treatment for people diagnosed with obstructive sleep apnea (OSA).
Two professors at Japan's International Institute for Integrative Sleep Medicine (WPI-IIIS) at the University of Tsukuba have developed a potent compound that promotes wakefulness and remedies narcolepsy in model animals.
A new position statement from the American Academy of Sleep Medicine (AASM) warns that drowsy driving is a serious public health concern requiring greater public awareness and increased efforts to improve preventive education.
PatientCrossroads recently launched the NEXUS Narcolepsy Registry, which is designed to describe the course of disease and treatment over time as well as to quantify the impact of narcolepsy on patients’ quality of life, daily functioning, productivity, and healthcare resource utilization.
Monday mornings could be harmful to your health. Even routine sleep changes such as waking up early for work during the week may raise the risk of developing metabolic problems such as diabetes and heart disease, according to a study.
Drinking a second or third cup of coffee may do more than get you through a long day—it may also reduce your risk of death from heart disease and other illnesses.
Thomas G. Schell, DMD, American Board of Dental Sleep Medicine Diplomate, has joined Sleep Review's editorial advisory board.
Developed by medical device inventor Richard Mills, SleepCogni—now seeking funding via Kickstarter—is a bedside sleep device that is backed by technology and supported by Sheffield Hallam University and international sleep expert and founder of the London Sleep Centre, Irshaad Ebrahim, MBChB, MRCPsych.
The Coriell Personalized Medicine Collaborative (CPMC), a research initiative exploring the utility of genetic information in the clinical setting, has published a study and identified six noteworthy genes that affect human sleep duration.
A new national survey on optimal room temperatures required for sleeping, which was conducted by Google Consumer Surveys last month and commissioned by heating and cooling company Aire Serv, shows that nearly 40% of American adults prefer to set their thermostats between 66 and 69 degrees Fahrenheit while sleeping.
Research and Markets has announced the addition of the "Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020" report to its offering.
Medtrade attendees were thirsty for knowledge this year, with registration for educational sessions up 17% over last year. Overall, non-exhibitor attendance at Medtrade, held from Oct 26-29, 2015, at the Georgia World Congress Center in Atlanta, registered a 1% jump when compared to last year.
MicroDental Laboratories is now offering a 3-year warranty for its MicrO2 Sleep Device. The MicrO2 is a CAD/CAM milled device made from control cured PMMA. Also new for MicroDental is the "Find a Doctor" search engine enabling MicrO2 prescribing dentists to be featured on the MicrO2SleepDevice.com website as a Preferred Provider.
Vancouver, Wash-based Oasis Diagnostics has entered into an agreement to license salivary diagnostic technology from scientists working in Denmark (Drs Balwant Rai and Jasdeep Kaur) for the detection, monitoring, and diagnosis of sleep disorders.
A Northwestern Medicine study has pinpointed thousands of genetic pathways an internal body clock takes to dictate how and when our pancreas must produce insulin and control blood sugar, findings that could eventually lead to new therapies for children and adults with diabetes.
Via a partnership with CleveMed and a new PAP management service, Welltrinsic aims to help sleep practices improve their efficiency and clinical outcomes.
Barbara Phillips, MD, professor of pulmonary, critical care and sleep medicine in the Department of Internal Medicine at the University of Kentucky, was elected the 78th president of The American College of Chest Physicians (CHEST) effective Nov 1, 2015.
Baby boomers believe in the value of prevention, but many of this generation are taking a reactive, and sometimes risky, approach when it comes to managing their health, as revealed by the first MDVIP Boomer Health Survey.
Pernix Therapeutics Holdings Inc, a specialty pharmaceutical company, today announced positive interim results from a Phase IV Study assessing the effects of a nighttime administration of Silenor 6mg, zolpidem 10mg, and placebo on arousability, gait/balance, and cognitive performance in healthy volunteers.